Hepatic encephalopathy;Hepatische enzephalopathie

Deutsche Medizinische Wochenschrift

Volumn 126, Issue SUPPL. 1, 2001, Pages

  Ferenci, P ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 5 HYDROXYINDOLEACETIC ACID; AMINOPENICILLIN; BENZODIAZEPINE; BROMOCRIPTINE; DISACCHARIDE; FLUMAZENIL; GLUCOSE; LACTULOSE; METRONIDAZOLE; NEOMYCIN; NEUROTRANSMITTER; ORNITHINE ASPARTATE; RIFAXIMIN; SEROTONIN; THIAMINE; TRYPTOPHAN; VANCOMYCIN; ZINC ACETATE;

CLINICAL TRIAL; ELECTROENCEPHALOGRAPHY; HEPATIC ENCEPHALOPATHY; HUMAN; LACTOBACILLUS BIFIDUS; NEPHROTOXICITY; NEUROTRANSMISSION; PSYCHOMETRY; REVIEW;

ACUTE DISEASE; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS;

EID: 0035367628     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-14502     Document Type: Review

References (58)

1. Visual attention in cirrhotic patients
2. Spectral versus visual EEG analysis in mild hepatic encephalopathy
3. Experimental hepatic encephalopathy - Changes in gamma-amino-butyric acid
4. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis
5. Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy
6. Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy
7. Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy
8. The astrocytic (»peripheral-type«) benzodiazepine receptor
9. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients
10. Effects of ammonia on glutamate transporter (GLAST) protein and mRNA in cultured rat cortical astrocytes
11. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy
12. Effect of portacaval anastomosis on glutamine synthetase protein and gene expression in brain, liver and skeletal muscle
13. Branched chain amino acids in the treatment of latent portosystemic encephalopathy
14. Effect of sodium benzoate on blood ammonia response to oral glutamine challenge in cirrhotic patients: A note of caution
15. Diagnosis and differential diagnosis of hepatic encephalopathy: Implications for the design of clinical studies
16. Hepatische enzephalopathie: Ernährung als ursache oder therapie?
17. False neurotransmitters and hepatic failure
18. Evidence for the role of ammonia in the intracerebral transfer and metabolism of tryptophan
19. Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomized, placebo-controlled multicenter trial
20. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy
21. The prognostic significance of subclinical hepatic encephalopathy
22. Hepatic encephalopathy in chronic liver disease: A clinical manifestation of astrocyte swelling and low-grade cerebral edema?
23. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double blind study
24. Comparison of ammonia partial pressure and total ammonia in hepatic encephalopathy
25. Manganese and chronic hepatic encephalopathy
26. Subclinical hepatic encephalopathy
27. Long-term effects of enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy
28. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis
29. A new therapy for portal systemic encephalopathy
30. Evidence for a serotonin transporter deficit in experimental acute liver failure
31. Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure
32. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: A double blind, randomized trial
33. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis
34. Clinical trials of nonabsorbable disaccharide therapy in hepatic encephalopathy
35. ESPEN Guidelines for nutrition in liver disease and transplantation
36. Flumazenil in cirrhotic patients in hepatic coma: A randomized double-blind placebo-controlled crossover trial
37. The diagnosis of subclinical encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis
38. Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: A double blind, placebo controlled trial
39. Oral zinc supplementation improves hepatic encephalopathy
40. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy
41. Subclinical hepatic encephalopathy
42. The amino acid content of food
43. Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis
44. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy
45. Sodium benzoate in the treatment of acute hepatic encephalopathy: A double-blind randomized trial
46. Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy
47. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: Results ora controlled randomized trial
48. Acidifying enemas (lactitol and lactulose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: A double-blind randomized clinical trial
49. Treatment of chronic portal systemic encephalopathy with lactose in lactase deficient patients
50. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study
51. Ovart hepatic encephalopathy precipitated by zinc deficiency
52. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats
53. Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects
54. The number connection tests A and B: Interindividual variability and use for the assessment of early hepatic encephalopathy
55. Elevated serum levels of astroglial S100beta in patients with liver cirrhosis indicate early and subclinical portal-systemic encephalopathy
56. Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists
57. Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide induced acute liver failure